These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
845 related items for PubMed ID: 17873821
21. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS. Anesth Analg; 2010 Jan 01; 110(1):21-9. PubMed ID: 19910626 [Abstract] [Full Text] [Related]
22. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China. Wang X, Zheng Z, Ao H, Zhang S, Wang Y, Zhang H, Li L, Hu S. J Thorac Cardiovasc Surg; 2009 Oct 01; 138(4):897-903. PubMed ID: 19660368 [Abstract] [Full Text] [Related]
23. Diabetes and early postoperative outcomes following lumbar fusion. Browne JA, Cook C, Pietrobon R, Bethel MA, Richardson WJ. Spine (Phila Pa 1976); 2007 Sep 15; 32(20):2214-9. PubMed ID: 17873813 [Abstract] [Full Text] [Related]
25. Aprotinin is safe in pediatric patients undergoing cardiac surgery. Backer CL, Kelle AM, Stewart RD, Suresh SC, Ali FN, Cohn RA, Seshadri R, Mavroudis C. J Thorac Cardiovasc Surg; 2007 Dec 15; 134(6):1421-6; discussion 1426-8. PubMed ID: 18023656 [Abstract] [Full Text] [Related]
26. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study. Jakobsen CJ, Søndergaard F, Hjortdal VE, Johnsen SP. Eur J Cardiothorac Surg; 2009 Nov 15; 36(5):863-8. PubMed ID: 19782573 [Abstract] [Full Text] [Related]
30. Role of Amicar in surgery for neuromuscular scoliosis. Thompson GH, Florentino-Pineda I, Poe-Kochert C, Armstrong DG, Son-Hing J. Spine (Phila Pa 1976); 2008 Nov 15; 33(24):2623-9. PubMed ID: 18981961 [Abstract] [Full Text] [Related]
31. [Use of high doses of aprotinin in cardiac surgery]. Carrera A, Martínez MV, García-Guiral M, Herrero E, Peral A, Planas A. Rev Esp Anestesiol Reanim; 1994 Nov 15; 41(1):13-9. PubMed ID: 7517058 [Abstract] [Full Text] [Related]
32. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Karkouti K, Beattie WS, Dattilo KM, McCluskey SA, Ghannam M, Hamdy A, Wijeysundera DN, Fedorko L, Yau TM. Transfusion; 2006 Mar 15; 46(3):327-38. PubMed ID: 16533273 [Abstract] [Full Text] [Related]
33. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia. Riddell RE, Buth KJ, Sullivan JA. Can J Anaesth; 2013 Jan 15; 60(1):16-23. PubMed ID: 23132043 [Abstract] [Full Text] [Related]
34. Aprotinin does not increase the risk of renal failure in cardiac surgery patients. Furnary AP, Wu Y, Hiratzka LF, Grunkemeier GL, Page US. Circulation; 2007 Sep 11; 116(11 Suppl):I127-33. PubMed ID: 17846292 [Abstract] [Full Text] [Related]
35. Short-term mortality and its association with independent risk factors in adult spinal deformity surgery. Pateder DB, Gonzales RA, Kebaish KM, Cohen DB, Chang JY, Kostuik JP. Spine (Phila Pa 1976); 2008 May 15; 33(11):1224-8. PubMed ID: 18469696 [Abstract] [Full Text] [Related]
39. Retrospective cohort analysis of a single dose of aprotinin use in children undergoing cardiac surgery: a single-center experience. Fan Y, Lin R, Yang L, Ye L, Yu J, Shu Q. Paediatr Anaesth; 2013 Mar 15; 23(3):242-9. PubMed ID: 23189963 [Abstract] [Full Text] [Related]